321 related articles for article (PubMed ID: 23670263)
1. [Molecular diagnostics in pathology].
Stenzinger A; Penzel R; Endris V; Weichert W
Dtsch Med Wochenschr; 2013 May; 138(20):1061-8. PubMed ID: 23670263
[TBL] [Abstract][Full Text] [Related]
2. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
3. How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.
Baudhuin LM; Donato LJ; Uphoff TS
Expert Rev Mol Diagn; 2012 Jan; 12(1):25-37. PubMed ID: 22133117
[TBL] [Abstract][Full Text] [Related]
4. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
5. Next-generation sequencing - feasibility and practicality in haematology.
Kohlmann A; Grossmann V; Nadarajah N; Haferlach T
Br J Haematol; 2013 Mar; 160(6):736-53. PubMed ID: 23294427
[TBL] [Abstract][Full Text] [Related]
6. Micromarkers: miRNAs in cancer diagnosis and prognosis.
Ferracin M; Veronese A; Negrini M
Expert Rev Mol Diagn; 2010 Apr; 10(3):297-308. PubMed ID: 20370587
[TBL] [Abstract][Full Text] [Related]
7. Molecular diagnostics of lung cancers at the Brigham and Women's Hospital and Dana-Farber Cancer Institute: technology in rapid evolution.
Lindeman N
Arch Pathol Lab Med; 2012 Oct; 136(10):1198-200. PubMed ID: 23020723
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnostics and personalized medicine in oncology: challenges and opportunities.
Normanno N; Rachiglio AM; Roma C; Fenizia F; Esposito C; Pasquale R; La Porta ML; Iannaccone A; Micheli F; Santangelo M; Bergantino F; Costantini S; De Luca A
J Cell Biochem; 2013 Mar; 114(3):514-24. PubMed ID: 22991232
[TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing and its applications in molecular diagnostics.
Su Z; Ning B; Fang H; Hong H; Perkins R; Tong W; Shi L
Expert Rev Mol Diagn; 2011 Apr; 11(3):333-43. PubMed ID: 21463242
[TBL] [Abstract][Full Text] [Related]
10. Highlights from the 7th European meeting on molecular diagnostics.
Loonen AJ; Schuurman R; van den Brule AJ
Expert Rev Mol Diagn; 2012 Jan; 12(1):17-9. PubMed ID: 22133115
[TBL] [Abstract][Full Text] [Related]
11. [Molecular diagnostics in oncology].
Imianitov EN
Vopr Onkol; 2012; 58(2):153-63. PubMed ID: 22774518
[No Abstract] [Full Text] [Related]
12. [Response predictive biomarkers to targeted therapies in oncology].
Harlé A; Merlin JL
Ann Biol Clin (Paris); 2013 Nov; 71():89-97. PubMed ID: 24235332
[TBL] [Abstract][Full Text] [Related]
13. Hybrid optoelectric techniques for molecular diagnostics.
Haque AU; Kumar A
Expert Rev Mol Diagn; 2012 Jan; 12(1):9-11. PubMed ID: 22133113
[No Abstract] [Full Text] [Related]
14. Molecular pathology as the driving force for personalized oncology.
Oktay MH; Hui P
Expert Rev Mol Diagn; 2012 Nov; 12(8):811-3. PubMed ID: 23249199
[TBL] [Abstract][Full Text] [Related]
15. Making molecular diagnostics ready for prime time.
Jonietz E
Cancer Discov; 2011 Nov; 1(6):OF1-3. PubMed ID: 22586659
[No Abstract] [Full Text] [Related]
16. Recent advances in biomarkers for cancer diagnosis and treatment.
Manne U; Srivastava RG; Srivastava S
Drug Discov Today; 2005 Jul; 10(14):965-76. PubMed ID: 16023055
[TBL] [Abstract][Full Text] [Related]
17. Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.
Walk EE
Curr Opin Drug Discov Devel; 2010 Mar; 13(2):226-34. PubMed ID: 20205056
[TBL] [Abstract][Full Text] [Related]
18. [Cytological material for molecular pathology].
Heukamp LC; Bubendorf L
Pathologe; 2015 Nov; 36(6):566-71. PubMed ID: 26483251
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous detection of clinically relevant mutations and amplifications for routine cancer pathology.
Hoogstraat M; Hinrichs JW; Besselink NJ; Radersma-van Loon JH; de Voijs CM; Peeters T; Nijman IJ; de Weger RA; Voest EE; Willems SM; Cuppen E; Koudijs MJ
J Mol Diagn; 2015 Jan; 17(1):10-8. PubMed ID: 25445215
[TBL] [Abstract][Full Text] [Related]
20. [The clinical molecular pathologist: beyond the image].
van Noesel CJ
Ned Tijdschr Geneeskd; 2011; 155(18):A2971. PubMed ID: 21466725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
